Report date: Jan 27,2026
Conflict count: 370687
Publisher: MedCrave Group Kft.
Title count: 16
Conflict count: 21


==========================================================

Created: 2026-01-08 12:24:08
ConfID: 8572656
CauseID: 1728515301
OtherID: 1728514891
JT: MOJ Addiction Medicine & Therapy
MD: Shafti,6,2,62,2019,Second generation antipsychotic as supplementary medication in treatment-resistant obsessive compulsive disorder
DOI: 10.15406/mojamt.2019.06.0014(Journal) (8572656-N)
DOI: 10.15406/mojamt.2019.06.00148(Journal)